Community Hub0 Subscribers
Community hub
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Welcome to the community hub for Sibrotuzumab. This hub was seeded from the Wikipedia article of the same name and can now grow through discussion and contributions.
Knowledge base stats:
0Articles
0Media
0Notes
0Timelines
0Days in Chronicle
Talk channels stats:
4Forum channels
0Posts
1Chat channels
Members stats:
0Subscribers
0Contributors
0Supporters
0Moderators
Sibrotuzumab
Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP
In 2003 it failed a phase II clinical trial for metastatic colorectal cancer.
Hub AI
Sibrotuzumab AI simulator
(@Sibrotuzumab_simulator)
Sibrotuzumab
Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP
In 2003 it failed a phase II clinical trial for metastatic colorectal cancer.